Underwriter rewrites pharma guide; Pfizer sells in Brooklyn;

> Best's Underwriting & Loss Control Center, prompted by recent lawsuits and recalls, has revised its report on pharma manufacturing to help underwriters identify insurance exposures. Announcement

> Pfizer has sold eight of 13 acres at its South Williamsburg complex in Brooklyn to Acumen Capital Partners for development. Article

> Canada shed more than 3,600 pharma jobs in the second half of 2010. Article

> Production-related jobs in Russia's pharma and energy sectors are showing a 15 to 20 percent salary rise over a year ago. Article

> Nigerian officials are using TruScan handheld Raman spectrometers in Ilorin, Kwara State, in a crackdown on counterfeit malaria drugs. Story

> Thermo Fisher Scientific has unveiled the TruScan RM handheld analyzer, a faster and smaller version of the TruScan analyzer, for raw materials identification and finished product inspection. Release

> Paralympic gold medalist Jim Armstrong has been fined $30,000 for selling counterfeit Viagra and Cialis pills following a Customs and Border Protection sting at his local Mail Boxes International store in Blaine, WA. Story

> United Therapeutics plans to expand in Research Triangle Park, NC, tripling its work force for manufacturing, packaging, labeling and warehousing. Item

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.